About this trial
Supraventricular arrhythmias complicate more than 40% of cardiac surgeries and are associated with an increased risk of bleeding, stroke, heart failure, and death. Preventing the occurrence of these arrhythmias is a major challenge. This study aims to investigate risk factors and protective factors regarding atrial fibrillation and other iatrogenic cardiac arrhythmias after cardiac surgery, particularly innovative anesthetic strategies such as stellar ganglion blockade which have been recently implemented in our center.
Eligibility criteria
Qualifiers
age >18
having undergone a scheduled cardiac surgery in the study center
having agreed to the reuse of their hospital care data
Disqualifiers
Atrial fibrillation at the admission in hospital.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Sponsors and collaborators
Centre Hospitalier Régional Metz-Thionville
Lead sponsor